Drug Type Small molecule drug |
Synonyms GL-1001, ORE-1001 |
Target |
Action inhibitors |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H23Cl2N3O4 |
InChIKeyNTCCRGGIJNDEAB-IRXDYDNUSA-N |
CAS Registry305335-31-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 2 | Canada | 01 Dec 2009 | |
Colitis, Ulcerative | Phase 2 | India | 01 Dec 2009 | |
Obesity | Phase 2 | - | - |